Trial Profile
MAP Study (Methotrexate and Adalimumab in Psoriasis): Adalimumab vs. Combination Adalimumab and Methotrexate in Psoriasis: Efficacy and Anti-Adalimumab Antibody Formation
Recruiting
Phase of Trial:
Phase II/III
Latest Information Update: 22 Jul 2017
At a glance
- Drugs Adalimumab (Primary) ; Methotrexate
- Indications Plaque psoriasis
- Focus Therapeutic Use
- Acronyms MAP Study
- 20 Jul 2017 New trial record